If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
484.40    1.60 (0.33%)
Bid:
484.40
Ask:
485.20
Spread: 0.80 (0.165%)
Market Cap: £2.49b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Directorate Change

23 Mar 2023 17:00

RNS Number : 0614U
QinetiQ Group plc
23 March 2023
 

QinetiQ Group plc

 

Board Changes

 

23 March 2023 - QinetiQ Group plc ('QinetiQ') today announces that Michael Harper, who has been a Non-executive Director since November 2011; and Deputy Chair and Senior Independent Director since January 2012, is to retire from the Board with effect from the conclusion of the 2023 Annual General Meeting ("AGM").

 

Following Michael's retirement, Steve Mogford, Non-executive Director, will become the Group's Senior Independent Director ("SID").

 

Commenting on today's announcement, Neil Johnson, Group Chair of QinetiQ, said:

 

"I would like to thank Michael for his consistently invaluable contribution to both the Board and the wider QinetiQ family. As Deputy Chair and SID, his wise counsel and the sharing of his wealth of experience, has been appreciated by all who have worked with him in pursuit of QinetiQ's global growth strategy. On a personal note, I would particularly like to thank Michael for his support, guidance and advice when I joined the Board, and subsequently as an outstanding SID and valued sounding board. He will be missed, and we all wish him well in a richly deserved retirement."

 

"We are indeed fortunate to have Steve Mogford, a Board member since August 2022, available to take on the SID role as Michael retires. Since joining the Board, Steve has brought the benefit of his wealth of experience in both executive and non-executive roles across a breadth of sectors, including international defence and security. This has enhanced the skill sets of our Board, and means he is extremely well equipped to take on the additional challenges of this role. I very much look forward to working with Steve as SID following the AGM."

 

9.6.11R of the Listing Rules of the UK Listing Authority:

 

This notice is given in fulfilment of the obligation under paragraph 9.6.11R of the Listing Rules. There are no other matters requiring disclosure under paragraph 9.6.11R.

 

S430(2B) Companies Act 2006:

 

Michael Harper has not and will not receive any loss of office payments, nor will he be paid any further remuneration for his service as a Director of QinetiQ Group plc, other than fees due for his services up to the date he retires from the Board.

 

About QinetiQ:

 

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence, security and critical infrastructure markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

 

For further information please contact:

 

John Haworth, Group Head of Investor Relations: +44 (0) 7920 545841

James Field, Company Secretary: +44 (0) 7841 662957

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEXLFLXXLFBBX
Date   Source Headline
11th Nov 20217:00 amRNSInterim Results
10th Nov 202112:12 pmRNSDirector/PDMR Shareholding
1st Nov 202111:43 amRNSBlock listing Interim Review
19th Oct 20219:16 amRNSHolding(s) in Company
14th Oct 20217:00 amRNSTrading Update
12th Oct 202110:43 amRNSDirector/PDMR Shareholding
10th Sep 20212:07 pmRNSDirector/PDMR Shareholding
31st Aug 20212:35 pmRNSDirector/PDMR Shareholding
11th Aug 20219:07 amRNSDirector/PDMR Shareholding
27th Jul 202110:46 amRNSDirectorate Change
26th Jul 20214:33 pmRNSDirector/PDMR Shareholding
21st Jul 202110:55 amRNSResult of AGM
21st Jul 20217:00 amRNSFirst Quarter Trading Update
14th Jul 20218:47 amRNSChange of AGM venue
13th Jul 20219:52 amRNSHolding(s) in Company
12th Jul 202111:12 amRNSDirector/PDMR Shareholding
2nd Jul 20217:00 amRNSChief Financial Officer succession
29th Jun 20213:49 pmRNSDirector/PDMR Shareholding
15th Jun 202110:55 amRNSAnnual Financial Report
10th Jun 202111:15 amRNSDirector/PDMR Shareholding
9th Jun 20215:01 pmRNSDirector/PDMR Shareholding
1st Jun 20219:34 amRNSTotal Voting Rights
25th May 202110:54 amRNSBlock Listing Application
20th May 20217:00 amRNSPreliminary Results
11th May 20211:53 pmRNSDirector/PDMR Shareholding
27th Apr 20212:08 pmRNSDeath of Non-Executive Director, Ian Mason
15th Apr 20212:49 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSTrading Update
12th Apr 20212:00 pmRNSDirector/PDMR Shareholding
12th Apr 20218:32 amRNSHolding(s) in Company
10th Mar 202112:23 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSInvestor Seminar
16th Feb 20218:55 amRNSDirector Declaration
10th Feb 202111:32 amRNSDirector/PDMR Shareholding
8th Feb 20219:57 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSThird Quarter Trading Update
12th Jan 20219:49 amRNSDirector/PDMR Shareholding
4th Jan 20217:00 amRNSQinetiQ wins £127m Typhoon contract through EDP
21st Dec 20204:44 pmRNSHolding(s) in Company
10th Dec 202010:28 amRNSDirector/PDMR Shareholding
3rd Dec 20201:00 pmRNSSale of OptaSense to Luna
24th Nov 20201:31 pmRNSDirector/PDMR Shareholding
20th Nov 202012:37 pmRNSDirector/PDMR Shareholding
20th Nov 202011:43 amRNSHolding(s) in Company
17th Nov 202011:16 amRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSInterim Results
10th Nov 202010:47 amRNSDirector/PDMR Shareholding
12th Oct 202010:09 amRNSDirector/PDMR Shareholding
5th Oct 20209:10 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSPre-close Trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.